The absence of a distinctive metabolomic profile in those with NMDAR/LGI1/CASPR2 serum antibodies in psychosis does not necessarily indicate that these antibodies are not having an effect in the brain in these patients. The gene discussed is CNTNAP2; the disease is psychotic disorder.